Vimarsana
Biggest News Aggregation in the World

Page 7 - Evercore Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evercore Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evercore Group Today - Breaking & Trending Today

DIGICEL ANNOUNCES SUCCESSFUL CLOSING OF CONSENSUAL RESTRUCTURING OF THE GROUP'S DEBT - Vimarsana News

DIGICEL ANNOUNCES SUCCESSFUL CLOSING OF CONSENSUAL RESTRUCTURING OF THE GROUP'S DEBT

Digicel Holdings (Bermuda) Limited (“DHL” and, together with its subsidiaries, the “Company” or the “Group”) and its board of directors are pleased to announce…

Conoco emerges as surprise bidder in historic Citgo share auction - Vimarsana News

Conoco emerges as surprise bidder in historic Citgo share auction

A U.S. court auction weighing the fate of Venezuela-owned oil refiner Citgo Petroleum has received bids using claims in lieu of cash, according to people familiar with the process and documents, part...

Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock - Vimarsana News

Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock

REDWOOD CITY, Calif., Feb. 06, 2024 -- Jasper Therapeutics, Inc. , a clinical-stage biotechnology company focused on developing novel antibody therapies targeting c-Kit to address diseases such...

Vaxcyte Announces Closing of $862.5 Million Public Offering - Vimarsana News

Vaxcyte Announces Closing of $862.5 Million Public Offering

SAN CARLOS, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity...

Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares -February 02, 2024 at 06:40 pm EST - Vimarsana News

Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares -February 02, 2024 at 06:40 pm EST

SAN CARLOS, Calif., Feb. 02, 2024 -- Vaxcyte, Inc. , a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases,...